A radioactive version of venom may deliver radiation therapy straight to brain cancer cells in humans.
Researchers at the Transmolecular Corporation in Cambridge, Mass. Said that the artificial version of the venom protein mixed with iodine-131 (I-131) may work as a radioactive substance.
Protein shows major empathy for cancer cells. It attracts to the cancer cells once entered the body. At the same time, the I-131 starts killing the cells.
The compound has been tested on the patients. It showed positive results on tumor activities with good endurance rates and any undesirable side effects.
Researchers are now planning to increase the radiation dose during the therapy. The high radiation dose may affect the patients as well as his family members. It is necessary to make sure the higher doses of radiation are safe for the patients’ families.
Read more here…